Results 241 to 250 of about 176,109 (361)

Increased implant thickness in mechanically aligned off-the-shelf total knee replacement compared to bone resection. [PDF]

open access: yesJ Exp Orthop
Calanna F   +7 more
europepmc   +1 more source

Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy

open access: yesBMEMat, EarlyView.
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim   +5 more
wiley   +1 more source

Baseline Plasma GDF15 and Recovery of Physical Function Following Total Knee Replacement in The Study of Physical Resilience and Aging. [PDF]

open access: yesJ Gerontol A Biol Sci Med Sci
Fountain WA   +13 more
europepmc   +1 more source

Optimizing Zeolite 13X Synthesis from Kaolin Clay for Higher CO2 Adsorption: A Statistical Approach

open access: yesChemCatChem, EarlyView.
Zeolite 13X is synthesized using kaolin clay as primary raw material through controlled variation of SiO2/Al2O3 ratio; aging time; crystallization temperature; and crystallization time. Statistical analysis identifies the influence of each synthesis parameter on CO2 adsorption capacity.
Apoorv Parikh, Nader Mahinpey
wiley   +1 more source

Local infiltration analgesia (LIA) gives superior analgesia compared to epidural analgesia after total knee replacement [PDF]

open access: yes, 2016
Allaert, Silvie   +5 more
core  

Quantitative Model‐Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
Milvexian, an activated factor XI inhibitor, is being evaluated in the LIBREXIA phase III program for the prevention of thrombotic events, including in patients with atrial fibrillation (LIBREXIA AF). To guide the selection of a phase III dose regimen for LIBREXIA AF, two main approaches were used: (1) population pharmacokinetics and exposure–response ...
Wangda Zhou   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy